Exploring how brain networks are affected by Alzheimer's disease and their ability to resist damage.
Understanding Selectivity Mechanisms of Network Vulnerability and Resilience in Alzheimer's Disease by Establishing a Neurobiological Basis through Network Neuroscience
This study looks at how Alzheimer's disease affects different parts of the brain and why some areas are more vulnerable than others, with the hope of finding new ways to help patients understand their condition and improve treatment options.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10875774 on NIH RePORTER |
What this research studies
This research investigates the specific ways Alzheimer's disease impacts different brain regions and cell types, focusing on how these changes affect the brain's network structure. By utilizing advanced neuroimaging and network analysis tools, the study aims to uncover the molecular mechanisms that lead to selective vulnerability in neurons and how some brain networks can resist the damaging effects of Alzheimer's pathology. Patients may benefit from a better understanding of their condition and potential new therapeutic strategies based on these findings.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or those showing early signs of cognitive decline.
Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and targeted therapies for Alzheimer's disease.
How similar studies have performed: Previous research has shown promising results in understanding network vulnerabilities in Alzheimer's, suggesting that this approach could yield valuable insights.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Wu, Guorong — Univ of North Carolina Chapel Hill
- Study coordinator: Wu, Guorong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.